Evidence map›Paper›PMID 31449713›Full record

ArticleAngewandte Chemie (International ed. in English)2019

Molybdenum Alkylidyne Complexes with Tripodal Silanolate Ligands: The Next Generation of Alkyne Metathesis Catalysts.

Julius Hillenbrand, Markus Leutzsch, Alois Fürstner

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Reactivity of a dAngewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Article
  4. Tripodal Silanolate Ligands Expand [MoXJournal of the American Chemical Society · 2025
    Article
  5. Metallacyclobutadienes: Intramolecular Rearrangement from Kinetic to Thermodynamic Isomers.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Article
  7. Article
  8. Total Synthesis of the Allenic Macrolide (+)-Archangiumide.Journal of the American Chemical Society · 2024
    Article
  9. Article
  10. Total Synthesis of Njaoamine C by Concurrent Macrocycle Formation.Journal of the American Chemical Society · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Ascent of Alkyne Metathesis to Strategy-Level Status.Journal of the American Chemical Society · 2021
    Article
  16. Article
  17. Article
  18. Triple Resonance Experiments for the Rapid Detection ofJournal of the American Chemical Society · 2021
    Article
  19. Article
  20. By-design molecular architecturesChemical science · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julius HillenbrandMax-Planck-Institut für Kohlenforschung, 45470, Mülheim/Ruhr, Germany.ORCID http://orcid.org/0000-0002-2646-1302
Markus LeutzschMax-Planck-Institut für Kohlenforschung, 45470, Mülheim/Ruhr, Germany.ORCID http://orcid.org/0000-0001-8171-9399
Alois FürstnerMax-Planck-Institut für Kohlenforschung, 45470, Mülheim/Ruhr, Germany.ORCID http://orcid.org/0000-0003-0098-3417

Funding

Max-Planck-Gesellschaft ##
6 · The paper itself

Abstract

A new type of molybdenum alkylidyne catalysts for alkyne metathesis is described, which is distinguished by an unconventional podand topology. These structurally well-defined complexes are easy to make on scale and proved to be tolerant toward numerous functional groups; even certain protic substituents were found to be compatible. The new catalysts were characterized by X-ray crystallography and by spectroscopic means, including

Indexed as

alkylidyne complexesalkyne metathesismolybdenumpodandssilanolate ligands

Identifiers

PMID31449713
PMCPMC6856820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.